Evaluation of effects of T and N type calcium channel blockers on the electroencephalogram recordings in Wistar Albino Glaxo/Rij rats, an absence epilepsy model

Indian J Pharmacol. 2015 Jan-Feb;47(1):34-8. doi: 10.4103/0253-7613.150324.

Abstract

Objectives: It is suggested that excessive calcium entry into neurons is the main triggering event in the initiation of epileptic discharges. We aimed to investigate the role of T and N type calcium channels in absence epilepsy experimental model.

Materials and methods: Wistar Albino Glaxo/Rij (WAG/Rij) rats (12-16 weeks old) were randomly allocated into four groups; sham, mibefradil (T type calcium channel blocker), w-Conotoxin MVIIA (N type calcium channel blocker), and mibefradil + w-Conotoxin MVIIA. Beta, alpha, theta, and delta wave ratios of EEG recordings and frequency and duration of spike wave discharges (SWDs) were analyzed and compared between groups.

Results: Beta and delta recording ratios in 1 μM/5 μl mibefradil group was significantly different from basal and other dose-injected groups. Beta, alpha, and theta recordings in 0.2 μM/5 μl w-Conotoxin MVIIA group was significantly different from basal and other dose-injected groups. In w-Conotoxin MVIIA after mibefradil group, beta, alpha, and theta recording ratios were significantly different from basal and mibefradil group. Mibefradil and w-Conotoxin MVIIA significantly decreased the frequency and duration of SWDs. The decrease of frequency and duration of SWDs in mibefradil group was significantly different from w-Conotoxin MVIIA group. The frequency and duration of SWDs significantly decreased in w-Conotoxin MVIIA after mibefradil group compared with basal, mibefradil, and w-Conotoxin MVIIA groups.

Conclusions: We concluded that both T and L type calcium channels play activator roles in SWDs and have positive effects on frequency and duration of these discharges. These results are related with their central effects more than peripheral effects.

Keywords: Epilepsy; T and N type calcium channels; Wistar Albino Glaxo/Rij rats; mibefradil; w-Conotoxin MVIIA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticonvulsants / pharmacology*
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / physiopathology
  • Brain Waves / drug effects*
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, N-Type / drug effects*
  • Calcium Channels, N-Type / metabolism
  • Calcium Channels, T-Type / drug effects*
  • Calcium Channels, T-Type / metabolism
  • Calcium Signaling / drug effects
  • Disease Models, Animal
  • Electroencephalography*
  • Epilepsy, Absence / metabolism
  • Epilepsy, Absence / physiopathology
  • Epilepsy, Absence / prevention & control*
  • Mibefradil / pharmacology*
  • Rats, Wistar
  • Time Factors
  • omega-Conotoxins / pharmacology*

Substances

  • Anticonvulsants
  • Calcium Channel Blockers
  • Calcium Channels, N-Type
  • Calcium Channels, T-Type
  • omega-Conotoxins
  • Mibefradil
  • ziconotide